Chemical approaches to therapeutically target the metabolism and signaling of the endocannabinoid 2-AG and eicosanoids
about
Cannabinoid-based drugs targeting CB1 and TRPV1, the sympathetic nervous system, and arthritisTranslational and emerging clinical applications of metabolomics in cardiovascular disease diagnosis and treatment.Exploring metabolic pathways and regulation through functional chemoproteomic and metabolomic platformsChemical genetics screening reveals KIAA1363 as a cytokine-lowering target.Biochemical properties and structure analysis of a DAG-Like lipase from Malassezia globosa.Monoacylglycerol Lipase Regulates Fever ResponseComprehensive Analysis of Structure-Activity Relationships of α-Ketoheterocycles as sn-1-Diacylglycerol Lipase α InhibitorsRapid and profound rewiring of brain lipid signaling networks by acute diacylglycerol lipase inhibition.Synthesis and Preclinical Evaluation of Sulfonamido-based [(11)C-Carbonyl]-Carbamates and Ureas for Imaging Monoacylglycerol Lipase.Chemical Genetic Approaches for the Investigation of Neutral Lipid Metabolism.Combination Chemistry: Structure-Activity Relationships of Novel Psychoactive Cannabinoids.Monoglyceride lipase as a drug target: At the crossroads of arachidonic acid metabolism and endocannabinoid signaling.Polyunsaturated fatty acids and endocannabinoids in health and disease.A natural substrate-based fluorescence assay for inhibitor screening on diacylglycerol lipase α.In Vitro and in Vivo Evaluation of 11C-Labeled Azetidinecarboxylates for Imaging Monoacylglycerol Lipase by PET Imaging Studies.Conversion of a Mono- and Diacylglycerol Lipase into a Triacylglycerol Lipase by Protein Engineering.Potential of Endocannabinoids to Control Bladder Pain.
P2860
Q26783956-FB0CF78E-DDBC-4F58-8D61-A58BD3C37278Q31082889-0E3EC29B-2D81-4730-B038-957D5E95C287Q34228026-1C619E2A-1B62-4CCE-B889-799A22465259Q34756802-A8F3378A-07B6-4BD2-A3A8-D1C035BD6384Q35380621-2F7EAF0C-6F64-455B-AA31-AF9DFD8AC7BEQ35750166-BDB028E6-C7E4-40C6-B47D-E880B994F0F9Q36403320-CAAF71B3-137D-4D51-B337-58C9AD13978CQ36459472-637879B5-2BDD-4832-A740-C65B5BF72C4EQ36970368-145FE78C-B4D7-4E7B-B533-AEEB46075F35Q38682493-A32C9FF0-A782-4940-8499-B4BDD799F704Q38983634-221C6F2F-1E89-45DC-A493-EC6171AA80D2Q39141240-A66BF006-1343-4C4F-8A91-6B1AEF43912BQ39421016-0E966D2A-4709-4BC1-9318-7D42D0828F7FQ41897358-AEE2EF32-4728-4DC4-94A6-629E674194E9Q52315796-40F59C6A-1D08-422D-B44E-D442D3205D8FQ53241554-528D20F4-283D-4D11-B78C-A2DFE1F29616Q55002764-F53A8B45-38F4-4582-A4EA-FF7EC2C64751
P2860
Chemical approaches to therapeutically target the metabolism and signaling of the endocannabinoid 2-AG and eicosanoids
description
2014 nî lūn-bûn
@nan
2014 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մարտին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Chemical approaches to therape ...... nnabinoid 2-AG and eicosanoids
@ast
Chemical approaches to therape ...... nnabinoid 2-AG and eicosanoids
@en
Chemical approaches to therape ...... nnabinoid 2-AG and eicosanoids
@nl
type
label
Chemical approaches to therape ...... nnabinoid 2-AG and eicosanoids
@ast
Chemical approaches to therape ...... nnabinoid 2-AG and eicosanoids
@en
Chemical approaches to therape ...... nnabinoid 2-AG and eicosanoids
@nl
prefLabel
Chemical approaches to therape ...... nnabinoid 2-AG and eicosanoids
@ast
Chemical approaches to therape ...... nnabinoid 2-AG and eicosanoids
@en
Chemical approaches to therape ...... nnabinoid 2-AG and eicosanoids
@nl
P2860
P356
P1476
Chemical approaches to therape ...... nnabinoid 2-AG and eicosanoids
@en
P2093
Daniel K Nomura
Rebecca A Kohnz
P2860
P304
P356
10.1039/C4CS00047A
P577
2014-03-28T00:00:00Z